Affymetrix promoted James Gibson, vice president of accounting and corporate controller, to principal accounting officer in December 2006.
In January, Illumina signed a collaborative agreement with the Mayo Clinic to codevelop molecular diagnostic tests for the study of complex diseases.
Partek’s Genomics Suite achieved GeneChip-compatible status for analysis of SNP association studies using Affymetrix’s Mapping Array system.
BioDiscovery joined Microsoft’s BioIT alliance.
Oxford Gene Technology (OGT) entered into a collaborative agreement with Agilent, giving OGT access to Agilent’s microarray platform, confirming OGT as an Agilent certified service provider and appointing Agilent as an OEM supplier for OGT-designed microarrays.
Affymetrix entered into a three-year translational medicine agreement with Vanderbilt-Ingram Cancer Center. Vanderbilt will use the Affymetrix Human Mitochondrial Resequencing Array 2.0 as part of its HIV/AIDS translational research.
Following the acquisition of Solexa by Illumina (see IBO 11/15/06), Solexa Board members Blaine Bowman and Roy Whitfield joined Illumina’s Board.
In February, Asuragen became the first certified service provider for Illumina gene expression profiling.
Illumina named deCODE genetics a certified service provider for Infinium genotyping.
SCHOTT Nexterion entered into a second license agreement with Accelr8 Technology for Accelr8’s OptiChem coatings.
PREMIER Biosoft and PamGene International BV will develop software for designing custom multiplex ligation-dependent probe amplification (MLPA) oligonucleotide probes for use with PamChip microarrays.
Jivan Biologics released SpliceFold software for the analysis of alternative splicing from microarray data.
Vidar Systems introduced the low-cost Revolution 4200 microarray scanner.
ExonHit Therapeutics SA launched the Human GW SpliceArray, available through its genomic services.
In February, Affymetrix released the single-chip SNP Array 5.0.
PREMIER Biosoft released TMA Foresight statistical software for tissue microarray data analysis.
BioFluidix launched the TopSpot E-Vision for printing microarrays.
Sales/Orders of Note
Affymetrix granted Tessarae access to its technology to develop and market epidemiological research tests for public health and biodefense surveillance.